Baldwin Wealth Partners’s Renalytix plc American Depositary Shares RNLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-1,000
Closed -$31K 679
2021
Q2
$31K Hold
1,000
﹤0.01% 417
2021
Q1
$26K Buy
+1,000
New +$25.1K ﹤0.01% 428

Other funds holding RNLX

Baldwin Wealth Partners's RNLX Position: Q3 2021 in Review

Baldwin Wealth Partners sold out of Renalytix plc American Depositary Shares (RNLX) in Q3 2021, closing a stake of 1,000 shares — an estimated $31K sold.

Baldwin Wealth Partners first reported a position in RNLX in Q1 2021 and held it in 2 quarters. The position peaked at $31K in Q2 2021. 31 funds tracked by Wall St. Rank hold RNLX as of Q3 2021.

  • Baldwin Wealth Partners reported no remaining Renalytix plc American Depositary Shares position as of Q3 2021 after selling out during the quarter.
  • Baldwin Wealth Partners sold 1,000 Renalytix plc American Depositary Shares shares in Q3 2021, an estimated $31K.
  • Baldwin Wealth Partners first reported a position in Renalytix plc American Depositary Shares in Q1 2021 and held it in 2 quarters.
  • Baldwin Wealth Partners's Renalytix plc American Depositary Shares position peaked at $31K in Q2 2021.
  • 31 funds tracked by Wall St. Rank held Renalytix plc American Depositary Shares as of Q3 2021.

Based on Baldwin Wealth Partners's 13F filing for Q3 2021, filed 27 Oct 2021.